Farinati F - Search Results

1

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.

Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, Naccarato R. Farinati F, et al. J Hepatol. 1990 Nov;11(3):297-301. doi: 10.1016/0168-8278(90)90211-9. J Hepatol. 1990. PMID: 1705274 Clinical Trial.

2

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.

Farinati F, De Maria N, Fornasiero A, Salvagnini M, Fagiuoli S, Chiaramonte M, Naccarato R. Farinati F, et al. Dig Dis Sci. 1992 May;37(5):659-62. doi: 10.1007/BF01296419. Dig Dis Sci. 1992. PMID: 1373360 Clinical Trial.

3

Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.

Farinati F, Fagiuoli S, De Maria N, Chiaramonte M, Aneloni V, Ongaro S, Salvagnini M, Naccarato R. Farinati F, et al. J Hepatol. 1992 Mar;14(2-3):183-7. doi: 10.1016/0168-8278(92)90156-j. J Hepatol. 1992. PMID: 1380021

4

Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis.

Farinati F, Cardin R, Zordan M, Valiante F, Garro AJ, Burra P, Venier P, Nitti D, Levis AG, Naccarato R. Farinati F, et al. Eur J Cancer Prev. 1992 Oct;1 Suppl 3:25-32. doi: 10.1097/00008469-199210003-00004. Eur J Cancer Prev. 1992. PMID: 1467786 Review. No abstract available.

5

Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.

Naccarato R, Farinati F. Naccarato R, et al. Among authors: farinati f. Dig Dis Sci. 1991 Aug;36(8):1137-42. doi: 10.1007/BF01297461. Dig Dis Sci. 1991. PMID: 1650691 Review.

6

Risk of hepatocellular carcinoma in alcoholic cirrhosis.

Farinati F, Fagiuoli S, de Maria N, Zotti S, Chiaramonte M, Salvagnini M, Naccarato R. Farinati F, et al. Liver. 1991 Jun;11(3):190-1. doi: 10.1111/j.1600-0676.1991.tb00514.x. Liver. 1991. PMID: 1653387 No abstract available.

7

Hormonal treatment of hepatocellular carcinoma.

Farinati F, De Maria N, Chiaramonte M, Fagiuoli S, Salvagnini M, Naccarato R. Farinati F, et al. J Hepatol. 1991 May;12(3):402. doi: 10.1016/0168-8278(91)90847-5. J Hepatol. 1991. PMID: 1658123 No abstract available.

8

Direct involvement of human gastric mucosa in the activation of alimentary pro-carcinogens.

Farinati F, Zordan M, Cardin R, Levis AG, Nitti D, Lise M, Valiante F, Naccarato R. Farinati F, et al. Eur J Cancer Prev. 1991 Oct;1(1):43-8. doi: 10.1097/00008469-199110000-00009. Eur J Cancer Prev. 1991. PMID: 1842683

9

Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer.

Farinati F, Annoni G, Donato MF, Nardelli P, Bertozzo A, De Maria N, Zotti S, Salvagnini M, Martinez D, Naccarato R. Farinati F, et al. J Gastroenterol Hepatol. 1990 Nov-Dec;5(6):633-8. doi: 10.1111/j.1440-1746.1990.tb01117.x. J Gastroenterol Hepatol. 1990. PMID: 1966598

10

Cholestatic jaundice as the presenting symptom of small cell lung cancer.

Martin A, Castagliuolo I, Mastropaolo G, Del Favero G, Di Mario F, Farinati F, Sturniolo G, Cecchetto A, Naccarato R. Martin A, et al. Among authors: farinati f. Ital J Gastroenterol. 1990 Feb;22(1):36-9. Ital J Gastroenterol. 1990. PMID: 1966703 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters